Key details on Alexion Pharmaceuticals (Ticker: ALXN)
- CUSIP: 015351109
- Is ALXN overvalued or undervalued? Run a discounted cash flow (DCF) valuation analysis on ALXN
Who owns Alexion Pharmaceuticals?
Is ALXN a good stock to own? Find out who bought Alexion Pharmaceuticals, who sold Alexion Pharmaceuticals (ALXN) stock, and who holds a large position in Alexion Pharmaceuticals.
|Fund Name||Number of Shares||Share Valuation||As Of|
|OTR - Nominee Name for The State Teachers Retirement Board of Ohio||100.55M||$100.55M||March 31, 2015|
|T. Rowe Price Associates||28.30M||$5.40B||Dec. 31, 2015|
|Capital Research Global Investors^||27.60M||$5.27B||Dec. 31, 2015|
|FMR||14.88M||$2.84B||Dec. 31, 2015|
|Vanguard||12.97M||$2.47B||Dec. 31, 2015|
|STATE STREET CORPORATION||8.82M||$1.68B||Dec. 31, 2015|
|Jennison Associates||7.35M||$1.40B||Dec. 31, 2015|
|Baker Bros. Advisors||6.54M||$1.25B||Dec. 31, 2015|
|Sands Capital Management||6.06M||$1.16B||Dec. 31, 2015|
|Wells Fargo & Company||5.98M||$1.14B||Dec. 31, 2015|
|BlackRock Institutional Trust Company, N.A.||5.59M||$1.07B||Dec. 31, 2015|
|VIKING GLOBAL INVESTORS||5.54M||$511.47M||June 30, 2013|
|JPMORGAN CHASE & CO||5.31M||$959.92M||June 30, 2015|
|Ameriprise Financial||5.21M||$992.95M||Dec. 31, 2015|
Who sold Alexion Pharmaceuticals?
|Fund Name||Date Sold||Number of Shares Sold||Share Valuation|
|Columbia Wanger Asset Management||Sept. 30, 2011||6.28M||$402.57M|